Global GLP-1 Peptide Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Glucagon-likepeptide-1 (GLP-1) is a hormone secreted by intestinal L cells. Its receptor (GLP-1R) is widely distributed in the central nervous system, cardiovascular system, muscles, and gastrointestinal tract. multiple organs and tissues. GLP-1 has glucose concentration-dependent hypoglycemic effects, and its receptor agonist (GLP-1RA) can simulate the physiological effects of GLP-1 and is an important drug for the treatment of diabetes and obesity. In addition, GLP-1RA also has protective effects on the cardiovascular system, kidneys, central nervous system, etc.
GLP-1 peptide drugs are often used to treat patients with type 2 diabetes. They can control blood sugar while also bringing weight loss and reducing cardiovascular risk.
According to our (Global Info Research) latest study, the global GLP-1 Peptide Drugs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global GLP-1 Peptide Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global GLP-1 Peptide Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
Global GLP-1 Peptide Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global GLP-1 Peptide Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global GLP-1 Peptide Drugs market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1 Peptide Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GLP-1 Peptide Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Novo Nordisk, Sanofi, GSK, Eli Lilly, Benemae Pharmaceutical, Hansoh Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
GLP-1 Peptide Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
GLP-1 Peptide Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe GLP-1 Peptide Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of GLP-1 Peptide Drugs, with revenue, gross margin, and global market share of GLP-1 Peptide Drugs from 2019 to 2024.
Chapter 3, the GLP-1 Peptide Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and GLP-1 Peptide Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of GLP-1 Peptide Drugs.
Chapter 13, to describe GLP-1 Peptide Drugs research findings and conclusion.
GLP-1 peptide drugs are often used to treat patients with type 2 diabetes. They can control blood sugar while also bringing weight loss and reducing cardiovascular risk.
According to our (Global Info Research) latest study, the global GLP-1 Peptide Drugs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global GLP-1 Peptide Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global GLP-1 Peptide Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
Global GLP-1 Peptide Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global GLP-1 Peptide Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global GLP-1 Peptide Drugs market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1 Peptide Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GLP-1 Peptide Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Novo Nordisk, Sanofi, GSK, Eli Lilly, Benemae Pharmaceutical, Hansoh Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
GLP-1 Peptide Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
GLP-1 Peptide Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Injection
- Oral
- Type 2 Diabetes
- Obesity
- Others
- AstraZeneca
- Novo Nordisk
- Sanofi
- GSK
- Eli Lilly
- Benemae Pharmaceutical
- Hansoh Pharmaceutical
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe GLP-1 Peptide Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of GLP-1 Peptide Drugs, with revenue, gross margin, and global market share of GLP-1 Peptide Drugs from 2019 to 2024.
Chapter 3, the GLP-1 Peptide Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and GLP-1 Peptide Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of GLP-1 Peptide Drugs.
Chapter 13, to describe GLP-1 Peptide Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of GLP-1 Peptide Drugs by Type
1.3.1 Overview: Global GLP-1 Peptide Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global GLP-1 Peptide Drugs Consumption Value Market Share by Type in 2023
1.3.3 Injection
1.3.4 Oral
1.4 Global GLP-1 Peptide Drugs Market by Application
1.4.1 Overview: Global GLP-1 Peptide Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Type 2 Diabetes
1.4.3 Obesity
1.4.4 Others
1.5 Global GLP-1 Peptide Drugs Market Size & Forecast
1.6 Global GLP-1 Peptide Drugs Market Size and Forecast by Region
1.6.1 Global GLP-1 Peptide Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global GLP-1 Peptide Drugs Market Size by Region, (2019-2030)
1.6.3 North America GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
1.6.6 South America GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca GLP-1 Peptide Drugs Product and Solutions
2.1.4 AstraZeneca GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk GLP-1 Peptide Drugs Product and Solutions
2.2.4 Novo Nordisk GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novo Nordisk Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi GLP-1 Peptide Drugs Product and Solutions
2.3.4 Sanofi GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK GLP-1 Peptide Drugs Product and Solutions
2.4.4 GSK GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GSK Recent Developments and Future Plans
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly GLP-1 Peptide Drugs Product and Solutions
2.5.4 Eli Lilly GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Eli Lilly Recent Developments and Future Plans
2.6 Benemae Pharmaceutical
2.6.1 Benemae Pharmaceutical Details
2.6.2 Benemae Pharmaceutical Major Business
2.6.3 Benemae Pharmaceutical GLP-1 Peptide Drugs Product and Solutions
2.6.4 Benemae Pharmaceutical GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Benemae Pharmaceutical Recent Developments and Future Plans
2.7 Hansoh Pharmaceutical
2.7.1 Hansoh Pharmaceutical Details
2.7.2 Hansoh Pharmaceutical Major Business
2.7.3 Hansoh Pharmaceutical GLP-1 Peptide Drugs Product and Solutions
2.7.4 Hansoh Pharmaceutical GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hansoh Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global GLP-1 Peptide Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of GLP-1 Peptide Drugs by Company Revenue
3.2.2 Top 3 GLP-1 Peptide Drugs Players Market Share in 2023
3.2.3 Top 6 GLP-1 Peptide Drugs Players Market Share in 2023
3.3 GLP-1 Peptide Drugs Market: Overall Company Footprint Analysis
3.3.1 GLP-1 Peptide Drugs Market: Region Footprint
3.3.2 GLP-1 Peptide Drugs Market: Company Product Type Footprint
3.3.3 GLP-1 Peptide Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global GLP-1 Peptide Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global GLP-1 Peptide Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global GLP-1 Peptide Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
6.2 North America GLP-1 Peptide Drugs Market Size by Application (2019-2030)
6.3 North America GLP-1 Peptide Drugs Market Size by Country
6.3.1 North America GLP-1 Peptide Drugs Consumption Value by Country (2019-2030)
6.3.2 United States GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
7.2 Europe GLP-1 Peptide Drugs Consumption Value by Application (2019-2030)
7.3 Europe GLP-1 Peptide Drugs Market Size by Country
7.3.1 Europe GLP-1 Peptide Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7.3.3 France GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific GLP-1 Peptide Drugs Market Size by Region
8.3.1 Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Region (2019-2030)
8.3.2 China GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.5 India GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
9.2 South America GLP-1 Peptide Drugs Consumption Value by Application (2019-2030)
9.3 South America GLP-1 Peptide Drugs Market Size by Country
9.3.1 South America GLP-1 Peptide Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa GLP-1 Peptide Drugs Market Size by Country
10.3.1 Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 GLP-1 Peptide Drugs Market Drivers
11.2 GLP-1 Peptide Drugs Market Restraints
11.3 GLP-1 Peptide Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 GLP-1 Peptide Drugs Industry Chain
12.2 GLP-1 Peptide Drugs Upstream Analysis
12.3 GLP-1 Peptide Drugs Midstream Analysis
12.4 GLP-1 Peptide Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of GLP-1 Peptide Drugs by Type
1.3.1 Overview: Global GLP-1 Peptide Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global GLP-1 Peptide Drugs Consumption Value Market Share by Type in 2023
1.3.3 Injection
1.3.4 Oral
1.4 Global GLP-1 Peptide Drugs Market by Application
1.4.1 Overview: Global GLP-1 Peptide Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Type 2 Diabetes
1.4.3 Obesity
1.4.4 Others
1.5 Global GLP-1 Peptide Drugs Market Size & Forecast
1.6 Global GLP-1 Peptide Drugs Market Size and Forecast by Region
1.6.1 Global GLP-1 Peptide Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global GLP-1 Peptide Drugs Market Size by Region, (2019-2030)
1.6.3 North America GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
1.6.6 South America GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa GLP-1 Peptide Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca GLP-1 Peptide Drugs Product and Solutions
2.1.4 AstraZeneca GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk GLP-1 Peptide Drugs Product and Solutions
2.2.4 Novo Nordisk GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novo Nordisk Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi GLP-1 Peptide Drugs Product and Solutions
2.3.4 Sanofi GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK GLP-1 Peptide Drugs Product and Solutions
2.4.4 GSK GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GSK Recent Developments and Future Plans
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly GLP-1 Peptide Drugs Product and Solutions
2.5.4 Eli Lilly GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Eli Lilly Recent Developments and Future Plans
2.6 Benemae Pharmaceutical
2.6.1 Benemae Pharmaceutical Details
2.6.2 Benemae Pharmaceutical Major Business
2.6.3 Benemae Pharmaceutical GLP-1 Peptide Drugs Product and Solutions
2.6.4 Benemae Pharmaceutical GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Benemae Pharmaceutical Recent Developments and Future Plans
2.7 Hansoh Pharmaceutical
2.7.1 Hansoh Pharmaceutical Details
2.7.2 Hansoh Pharmaceutical Major Business
2.7.3 Hansoh Pharmaceutical GLP-1 Peptide Drugs Product and Solutions
2.7.4 Hansoh Pharmaceutical GLP-1 Peptide Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hansoh Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global GLP-1 Peptide Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of GLP-1 Peptide Drugs by Company Revenue
3.2.2 Top 3 GLP-1 Peptide Drugs Players Market Share in 2023
3.2.3 Top 6 GLP-1 Peptide Drugs Players Market Share in 2023
3.3 GLP-1 Peptide Drugs Market: Overall Company Footprint Analysis
3.3.1 GLP-1 Peptide Drugs Market: Region Footprint
3.3.2 GLP-1 Peptide Drugs Market: Company Product Type Footprint
3.3.3 GLP-1 Peptide Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global GLP-1 Peptide Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global GLP-1 Peptide Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global GLP-1 Peptide Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
6.2 North America GLP-1 Peptide Drugs Market Size by Application (2019-2030)
6.3 North America GLP-1 Peptide Drugs Market Size by Country
6.3.1 North America GLP-1 Peptide Drugs Consumption Value by Country (2019-2030)
6.3.2 United States GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
7.2 Europe GLP-1 Peptide Drugs Consumption Value by Application (2019-2030)
7.3 Europe GLP-1 Peptide Drugs Market Size by Country
7.3.1 Europe GLP-1 Peptide Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7.3.3 France GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific GLP-1 Peptide Drugs Market Size by Region
8.3.1 Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Region (2019-2030)
8.3.2 China GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.5 India GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
9.2 South America GLP-1 Peptide Drugs Consumption Value by Application (2019-2030)
9.3 South America GLP-1 Peptide Drugs Market Size by Country
9.3.1 South America GLP-1 Peptide Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa GLP-1 Peptide Drugs Market Size by Country
10.3.1 Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE GLP-1 Peptide Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 GLP-1 Peptide Drugs Market Drivers
11.2 GLP-1 Peptide Drugs Market Restraints
11.3 GLP-1 Peptide Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 GLP-1 Peptide Drugs Industry Chain
12.2 GLP-1 Peptide Drugs Upstream Analysis
12.3 GLP-1 Peptide Drugs Midstream Analysis
12.4 GLP-1 Peptide Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global GLP-1 Peptide Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global GLP-1 Peptide Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global GLP-1 Peptide Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global GLP-1 Peptide Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca Major Business
Table 7. AstraZeneca GLP-1 Peptide Drugs Product and Solutions
Table 8. AstraZeneca GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. AstraZeneca Recent Developments and Future Plans
Table 10. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 11. Novo Nordisk Major Business
Table 12. Novo Nordisk GLP-1 Peptide Drugs Product and Solutions
Table 13. Novo Nordisk GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novo Nordisk Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi GLP-1 Peptide Drugs Product and Solutions
Table 18. Sanofi GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GSK Company Information, Head Office, and Major Competitors
Table 20. GSK Major Business
Table 21. GSK GLP-1 Peptide Drugs Product and Solutions
Table 22. GSK GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. GSK Recent Developments and Future Plans
Table 24. Eli Lilly Company Information, Head Office, and Major Competitors
Table 25. Eli Lilly Major Business
Table 26. Eli Lilly GLP-1 Peptide Drugs Product and Solutions
Table 27. Eli Lilly GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Eli Lilly Recent Developments and Future Plans
Table 29. Benemae Pharmaceutical Company Information, Head Office, and Major Competitors
Table 30. Benemae Pharmaceutical Major Business
Table 31. Benemae Pharmaceutical GLP-1 Peptide Drugs Product and Solutions
Table 32. Benemae Pharmaceutical GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. Benemae Pharmaceutical Recent Developments and Future Plans
Table 34. Hansoh Pharmaceutical Company Information, Head Office, and Major Competitors
Table 35. Hansoh Pharmaceutical Major Business
Table 36. Hansoh Pharmaceutical GLP-1 Peptide Drugs Product and Solutions
Table 37. Hansoh Pharmaceutical GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Hansoh Pharmaceutical Recent Developments and Future Plans
Table 39. Global GLP-1 Peptide Drugs Revenue (USD Million) by Players (2019-2024)
Table 40. Global GLP-1 Peptide Drugs Revenue Share by Players (2019-2024)
Table 41. Breakdown of GLP-1 Peptide Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 42. Market Position of Players in GLP-1 Peptide Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 43. Head Office of Key GLP-1 Peptide Drugs Players
Table 44. GLP-1 Peptide Drugs Market: Company Product Type Footprint
Table 45. GLP-1 Peptide Drugs Market: Company Product Application Footprint
Table 46. GLP-1 Peptide Drugs New Market Entrants and Barriers to Market Entry
Table 47. GLP-1 Peptide Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 48. Global GLP-1 Peptide Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 49. Global GLP-1 Peptide Drugs Consumption Value Share by Type (2019-2024)
Table 50. Global GLP-1 Peptide Drugs Consumption Value Forecast by Type (2025-2030)
Table 51. Global GLP-1 Peptide Drugs Consumption Value by Application (2019-2024)
Table 52. Global GLP-1 Peptide Drugs Consumption Value Forecast by Application (2025-2030)
Table 53. North America GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 54. North America GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 55. North America GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 56. North America GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 57. North America GLP-1 Peptide Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 58. North America GLP-1 Peptide Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 59. Europe GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 60. Europe GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 61. Europe GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Europe GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Europe GLP-1 Peptide Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 64. Europe GLP-1 Peptide Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 65. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 68. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 69. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 71. South America GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 72. South America GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 73. South America GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 74. South America GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 75. South America GLP-1 Peptide Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 76. South America GLP-1 Peptide Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 77. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 78. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 79. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 80. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 81. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 82. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Global Key Players of GLP-1 Peptide Drugs Upstream (Raw Materials)
Table 84. Global GLP-1 Peptide Drugs Typical Customers
List of Figures
Figure 1. GLP-1 Peptide Drugs Picture
Figure 2. Global GLP-1 Peptide Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global GLP-1 Peptide Drugs Consumption Value Market Share by Type in 2023
Figure 4. Injection
Figure 5. Oral
Figure 6. Global GLP-1 Peptide Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. GLP-1 Peptide Drugs Consumption Value Market Share by Application in 2023
Figure 8. Type 2 Diabetes Picture
Figure 9. Obesity Picture
Figure 10. Others Picture
Figure 11. Global GLP-1 Peptide Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global GLP-1 Peptide Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market GLP-1 Peptide Drugs Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 14. Global GLP-1 Peptide Drugs Consumption Value Market Share by Region (2019-2030)
Figure 15. Global GLP-1 Peptide Drugs Consumption Value Market Share by Region in 2023
Figure 16. North America GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. South America GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East & Africa GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global GLP-1 Peptide Drugs Revenue Share by Players in 2023
Figure 23. GLP-1 Peptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 24. Market Share of GLP-1 Peptide Drugs by Player Revenue in 2023
Figure 25. Top 3 GLP-1 Peptide Drugs Players Market Share in 2023
Figure 26. Top 6 GLP-1 Peptide Drugs Players Market Share in 2023
Figure 27. Global GLP-1 Peptide Drugs Consumption Value Share by Type (2019-2024)
Figure 28. Global GLP-1 Peptide Drugs Market Share Forecast by Type (2025-2030)
Figure 29. Global GLP-1 Peptide Drugs Consumption Value Share by Application (2019-2024)
Figure 30. Global GLP-1 Peptide Drugs Market Share Forecast by Application (2025-2030)
Figure 31. North America GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. North America GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 33. North America GLP-1 Peptide Drugs Consumption Value Market Share by Country (2019-2030)
Figure 34. United States GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe GLP-1 Peptide Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. France GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific GLP-1 Peptide Drugs Consumption Value Market Share by Region (2019-2030)
Figure 48. China GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. India GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South America GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 55. South America GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 56. South America GLP-1 Peptide Drugs Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East & Africa GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East & Africa GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East & Africa GLP-1 Peptide Drugs Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. GLP-1 Peptide Drugs Market Drivers
Figure 66. GLP-1 Peptide Drugs Market Restraints
Figure 67. GLP-1 Peptide Drugs Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. GLP-1 Peptide Drugs Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Table 1. Global GLP-1 Peptide Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global GLP-1 Peptide Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global GLP-1 Peptide Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global GLP-1 Peptide Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca Major Business
Table 7. AstraZeneca GLP-1 Peptide Drugs Product and Solutions
Table 8. AstraZeneca GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. AstraZeneca Recent Developments and Future Plans
Table 10. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 11. Novo Nordisk Major Business
Table 12. Novo Nordisk GLP-1 Peptide Drugs Product and Solutions
Table 13. Novo Nordisk GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novo Nordisk Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi GLP-1 Peptide Drugs Product and Solutions
Table 18. Sanofi GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GSK Company Information, Head Office, and Major Competitors
Table 20. GSK Major Business
Table 21. GSK GLP-1 Peptide Drugs Product and Solutions
Table 22. GSK GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. GSK Recent Developments and Future Plans
Table 24. Eli Lilly Company Information, Head Office, and Major Competitors
Table 25. Eli Lilly Major Business
Table 26. Eli Lilly GLP-1 Peptide Drugs Product and Solutions
Table 27. Eli Lilly GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Eli Lilly Recent Developments and Future Plans
Table 29. Benemae Pharmaceutical Company Information, Head Office, and Major Competitors
Table 30. Benemae Pharmaceutical Major Business
Table 31. Benemae Pharmaceutical GLP-1 Peptide Drugs Product and Solutions
Table 32. Benemae Pharmaceutical GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. Benemae Pharmaceutical Recent Developments and Future Plans
Table 34. Hansoh Pharmaceutical Company Information, Head Office, and Major Competitors
Table 35. Hansoh Pharmaceutical Major Business
Table 36. Hansoh Pharmaceutical GLP-1 Peptide Drugs Product and Solutions
Table 37. Hansoh Pharmaceutical GLP-1 Peptide Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Hansoh Pharmaceutical Recent Developments and Future Plans
Table 39. Global GLP-1 Peptide Drugs Revenue (USD Million) by Players (2019-2024)
Table 40. Global GLP-1 Peptide Drugs Revenue Share by Players (2019-2024)
Table 41. Breakdown of GLP-1 Peptide Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 42. Market Position of Players in GLP-1 Peptide Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 43. Head Office of Key GLP-1 Peptide Drugs Players
Table 44. GLP-1 Peptide Drugs Market: Company Product Type Footprint
Table 45. GLP-1 Peptide Drugs Market: Company Product Application Footprint
Table 46. GLP-1 Peptide Drugs New Market Entrants and Barriers to Market Entry
Table 47. GLP-1 Peptide Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 48. Global GLP-1 Peptide Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 49. Global GLP-1 Peptide Drugs Consumption Value Share by Type (2019-2024)
Table 50. Global GLP-1 Peptide Drugs Consumption Value Forecast by Type (2025-2030)
Table 51. Global GLP-1 Peptide Drugs Consumption Value by Application (2019-2024)
Table 52. Global GLP-1 Peptide Drugs Consumption Value Forecast by Application (2025-2030)
Table 53. North America GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 54. North America GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 55. North America GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 56. North America GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 57. North America GLP-1 Peptide Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 58. North America GLP-1 Peptide Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 59. Europe GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 60. Europe GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 61. Europe GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Europe GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Europe GLP-1 Peptide Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 64. Europe GLP-1 Peptide Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 65. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 68. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 69. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Asia-Pacific GLP-1 Peptide Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 71. South America GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 72. South America GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 73. South America GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 74. South America GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 75. South America GLP-1 Peptide Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 76. South America GLP-1 Peptide Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 77. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 78. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 79. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 80. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 81. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 82. Middle East & Africa GLP-1 Peptide Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Global Key Players of GLP-1 Peptide Drugs Upstream (Raw Materials)
Table 84. Global GLP-1 Peptide Drugs Typical Customers
List of Figures
Figure 1. GLP-1 Peptide Drugs Picture
Figure 2. Global GLP-1 Peptide Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global GLP-1 Peptide Drugs Consumption Value Market Share by Type in 2023
Figure 4. Injection
Figure 5. Oral
Figure 6. Global GLP-1 Peptide Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. GLP-1 Peptide Drugs Consumption Value Market Share by Application in 2023
Figure 8. Type 2 Diabetes Picture
Figure 9. Obesity Picture
Figure 10. Others Picture
Figure 11. Global GLP-1 Peptide Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global GLP-1 Peptide Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market GLP-1 Peptide Drugs Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 14. Global GLP-1 Peptide Drugs Consumption Value Market Share by Region (2019-2030)
Figure 15. Global GLP-1 Peptide Drugs Consumption Value Market Share by Region in 2023
Figure 16. North America GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. South America GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East & Africa GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global GLP-1 Peptide Drugs Revenue Share by Players in 2023
Figure 23. GLP-1 Peptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 24. Market Share of GLP-1 Peptide Drugs by Player Revenue in 2023
Figure 25. Top 3 GLP-1 Peptide Drugs Players Market Share in 2023
Figure 26. Top 6 GLP-1 Peptide Drugs Players Market Share in 2023
Figure 27. Global GLP-1 Peptide Drugs Consumption Value Share by Type (2019-2024)
Figure 28. Global GLP-1 Peptide Drugs Market Share Forecast by Type (2025-2030)
Figure 29. Global GLP-1 Peptide Drugs Consumption Value Share by Application (2019-2024)
Figure 30. Global GLP-1 Peptide Drugs Market Share Forecast by Application (2025-2030)
Figure 31. North America GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. North America GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 33. North America GLP-1 Peptide Drugs Consumption Value Market Share by Country (2019-2030)
Figure 34. United States GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe GLP-1 Peptide Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. France GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific GLP-1 Peptide Drugs Consumption Value Market Share by Region (2019-2030)
Figure 48. China GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. India GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South America GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 55. South America GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 56. South America GLP-1 Peptide Drugs Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East & Africa GLP-1 Peptide Drugs Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East & Africa GLP-1 Peptide Drugs Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East & Africa GLP-1 Peptide Drugs Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE GLP-1 Peptide Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. GLP-1 Peptide Drugs Market Drivers
Figure 66. GLP-1 Peptide Drugs Market Restraints
Figure 67. GLP-1 Peptide Drugs Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. GLP-1 Peptide Drugs Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
